EMERGENT BIOSOLUTIONS INC. Deferred Tax Liabilities, Net, Current
EMERGENT BIOSOLUTIONS INC. (EBS) had Deferred Tax Liabilities, Net, Current of $88.00 thousand as of 2014-09-30, per its 10-Q filed 2014-11-10.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxLiabilitiesCurrent · last filed 2014-11-10
- 2014-09-30: Deferred Tax Liabilities, Net, Current $88.00K.
- 2014-06-30: Deferred Tax Liabilities, Net, Current $88.00K.
- 2014-03-31: Deferred Tax Liabilities, Net, Current $88.00K.
- 2013-12-31: Deferred Tax Liabilities, Net, Current $88.00K.
| Period end | Deferred Tax Liabilities, Net, Current |
|---|---|
| 2014-09-30 | $88.00K 10-Q · filed 2014-11-10 |
| 2014-06-30 | $88.00K 10-Q · filed 2014-08-08 |
| 2014-03-31 | $88.00K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $88.00K 10-Q · filed 2014-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |